Insider · CIK 0001781026

Parks Diane L.

Reports to the SEC for 4 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001781026

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6 sh	—	—	0
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−128 sh	—	—	0
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−56 sh	—	—	0
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−63 sh	—	—	0
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−121 sh	—	—	0
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−192 sh	—	—	0
2026-09-17	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+78.9K sh	—	—	78,947
2026-06-04	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+35K sh	—	—	35,000
2026-01-12	CELUCelularity IncA Award	Director	AAward	+30K sh	—	—	520,021
2026-01-12	CELUCelularity IncA Award	Director	AAward	+30K sh	—	—	520,021
2025-12-29	CELUCelularity IncA Award	Director	AAward	+125K sh	—	—	490,021
2025-12-29	CELUCelularity Inc · Stock OptionsA Award	Director	AAward	+156K sh	—	—	518,774
2025-12-19	CELUCelularity IncA Award	Director	AAward	+67.4K sh	—	—	365,021
2025-11-19	CELUCelularity IncA Award	Director	AAward	+61.5K sh	—	—	365,021
2025-06-20	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,647
2025-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+28.5K sh	—	—	28,500
2024-12-19	CELUCelularity IncA Award	Director	AAward	+67.4K sh	—	—	303,482
2024-12-19	CELUCelularity Inc · Stock Option (Right to Buy)A Award	Director	AAward	+84.7K sh	—	—	362,524
2024-12-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+8,646 sh	—	—	8,646
2024-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+26K sh	—	—	26,000
2023-12-15	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+38.1K sh	—	—	38,136
2023-06-26	CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−120K sh	—	—	0
2023-06-26	CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−80K sh	—	—	0
2023-06-26	CTI BIOPHARMA CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−80K sh	—	—	0
2023-06-14	CELUCelularity IncA Award	Director	AAward	+200K sh	—	—	236,066
2023-06-14	CELUCelularity Inc · Stock Option (Right to Buy)A Award	Director	AAward	+278K sh	—	—	277,778
2023-05-31	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+26K sh	—	—	26,000
2023-04-05	CTI BIOPHARMA CORPStock Option (right to buy)A Award	Director	AAward	+80K sh	—	—	80,000
2022-11-17	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+46.2K sh	—	—	112,504
2022-07-13	CELUCelularity IncA Award	Director	AAward	+36.1K sh	—	—	36,145
2022-07-13	CELUCelularity Inc · Stock Option (Right to Buy)A Award	Director	AAward	+54.2K sh	—	—	54,152
2022-06-21	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+23K sh	—	—	23,000
2022-06-02	CELUCelularity Inc · Stock Option (Right to Buy)A Award	Director	AAward	+42.4K sh	—	—	42,413
2022-03-09	CTI BIOPHARMA CORPStock Option (right to buy)A Award	Director	AAward	+80K sh	—	—	80,000
2021-09-23	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+29.1K sh	—	—	29,126
2021-06-22	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+23K sh	—	—	23,000
2020-09-16	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15.2K sh	—	—	15,228
2020-06-24	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+23K sh	—	—	23,000
2020-06-18	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2019-10-14	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+30K sh	—	—	30,000
2019-10-14	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+8,666 sh	—	—	8,666
2019-09-23	SNGXSOLIGENIX, INC.P Purchase	Director	PPurchase	+14.9K sh	$0.93	+$13.9K	14,940
2019-09-06	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+30.9K sh	—	—	30,928
2019-07-08	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,500 sh	—	—	1,500

Recent filings

Accepted (ET)
Oct 134
Parks Diane L.0001781026-26-000004
SEC(opens sec.gov)
Sep 184
Parks Diane L.0001781026-26-000002
SEC(opens sec.gov)
Jun 44
Parks Diane L.0001193125-26-257903
SEC(opens sec.gov)
Jan 154/A
Parks Diane L.0001493152-26-002427
SEC(opens sec.gov)
Jan 144
Parks Diane L.0001493152-26-002297
SEC(opens sec.gov)
Dec 304
Parks Diane L.0001493152-25-029615
SEC(opens sec.gov)
Dec 224
Parks Diane L.0001493152-25-028787
SEC(opens sec.gov)
Nov 214
Parks Diane L.0001493152-25-024634
SEC(opens sec.gov)
Jun 204
Parks Diane L.0001415889-25-017855
SEC(opens sec.gov)
Jun 64
Parks Diane L.0000950170-25-083040
SEC(opens sec.gov)
Jan 74
Parks Diane L.0001493152-25-001221
SEC(opens sec.gov)
Dec 134
Parks Diane L.0001415889-24-029351
SEC(opens sec.gov)
Jun 74
Parks Diane L.0000950170-24-070700
SEC(opens sec.gov)

Companies

Address

C/O SOLIGENIX, INC. 29 EMMONS DRIVE, SUITE B-10

PRINCETON, NJ, 08540